EIR Janssen Pharmaceuticals, dba Actelion Pharmaceutical Feb 2019

Thea Grome FDA$595.00 - Available Now

FDA investigators audited the Janssen Pharmaceuticals, dba Actelion Pharmaceutical - South San Francisco, CA, United States facility and issued inspectional observation (via FDA 483) on 28 Feb 2019.

Product details

  • Category:
  • Inspection end: 28 Feb 2019
  • Location: South San Francisco, United States
  • FEI: 3003498827
Add To Cart